NCT00344201

Brief Summary

Tisseel fibrin adhesive has been used extensively in many forms of surgery. Its use in eye surgery has been relatively recent. A few studies recently showed it was effective in securing conjunctival grafts in pterygium surgery, and in securing wounds after glaucoma and squint surgery. We sought to confirm its effectiveness in pterygium surgery, as well as prove its effectiveness in securing other material to the ocular surface such as amniotic membrane. Our hypothesis is that fibrin adhesive is effective in securing various types of material to the ocular surface for a sufficient length of time to allow adequate healing before it is absorbed and degraded.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Nov 2004

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2004

Completed
1.6 years until next milestone

First Submitted

Initial submission to the registry

June 23, 2006

Completed
3 days until next milestone

First Posted

Study publicly available on registry

June 26, 2006

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2007

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2008

Completed
Last Updated

May 12, 2010

Status Verified

May 1, 2010

Enrollment Period

2.2 years

First QC Date

June 23, 2006

Last Update Submit

May 11, 2010

Conditions

Keywords

PterygiumFibrin adhesiveConjunctival graftOcular surface reconstruction

Outcome Measures

Primary Outcomes (2)

  • Graft dislocation

    3 months

  • Pterygium recurrence

    6 months

Secondary Outcomes (3)

  • Graft dimensions

    6 months

  • Patient comfort on visual analogue scale

    1 month

  • Visual acuity

    6 months

Interventions

Intraoperative application to scleral bed and graft

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • significant pterygium clinically requiring excision
  • willingness to participate in research project and to attend research clinic

You may not qualify if:

  • age \< 18 years
  • other concurrent corneal pathology
  • poor acuity due to other ocular pathology
  • poor general health

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Singapore National Eye Centre

Singapore, 168751, Singapore

Location

Related Publications (5)

  • Tan DT, Chee SP, Dear KB, Lim AS. Effect of pterygium morphology on pterygium recurrence in a controlled trial comparing conjunctival autografting with bare sclera excision. Arch Ophthalmol. 1997 Oct;115(10):1235-40. doi: 10.1001/archopht.1997.01100160405001.

    PMID: 9338666BACKGROUND
  • Koranyi G, Seregard S, Kopp ED. Cut and paste: a no suture, small incision approach to pterygium surgery. Br J Ophthalmol. 2004 Jul;88(7):911-4. doi: 10.1136/bjo.2003.032854.

    PMID: 15205236BACKGROUND
  • Cohen RA, McDonald MB. Fixation of conjunctival autografts with an organic tissue adhesive. Arch Ophthalmol. 1993 Sep;111(9):1167-8. doi: 10.1001/archopht.1993.01090090017006. No abstract available.

    PMID: 8363455BACKGROUND
  • Biedner B, Rosenthal G. Conjunctival closure in strabismus surgery: Vicryl versus fibrin glue. Ophthalmic Surg Lasers. 1996 Nov;27(11):967.

    PMID: 8938809BACKGROUND
  • Schlag G , Redl H. Fibrin Sealant in Operative Medicine. Vol 2.Ophthalmology, neurosurgery. Berlin, Heidelberg: Springer Verlag, 1986.

    BACKGROUND

MeSH Terms

Conditions

Pterygium

Condition Hierarchy (Ancestors)

Conjunctival DiseasesEye Diseases

Study Officials

  • Donald TH Tan, FRCOphth

    Singapore Eye Research Institute

    PRINCIPAL INVESTIGATOR
  • Yong M Por, FRCS

    Singapore National Eye Centre

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER GOV

Study Record Dates

First Submitted

June 23, 2006

First Posted

June 26, 2006

Study Start

November 1, 2004

Primary Completion

January 1, 2007

Study Completion

January 1, 2008

Last Updated

May 12, 2010

Record last verified: 2010-05

Locations